11:09 AM EDT, 07/18/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were slightly higher late Friday morning, up 0.11% to 1,475.45 on the S&P Europe Select ADR Index, which ended the week more than 1% lower.

From continental Europe, the gainers were led by biopharmaceutical companies Genfit ( GNFT ) and DBV Technologies ( DBVT ) , which advanced 2.6% and 5% respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and oil and gas company TotalEnergies (TTE), which were up 0.1% and 0.6% respectively.

The decliners from continental Europe were led by semiconductor company Sequans Communications ( SQNS ) and internet browser company Opera (OPRA), which fell 7% and 0.9% respectively. They were followed by biopharmaceutical company Cellectis ( CLLS ) and internet advertising firm Criteo ( CRTO ) , which were down 1.6% and 0.5% respectively.

From the UK and Ireland, the gainers were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Mereo BioPharma Group ( MREO ) , which increased 2.5% and 3.1% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and utilities company National Grid ( NGG ) , which rose 1.5% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company NuCana ( NCNA ) , which lost 4.9%. They were followed by biopharmaceutical company Akari Therapeutics ( AKTX ) and financial services company Barclays ( BCS ) , which were off 0.1% and 0.8% respectively.